INVESTOR RELATIONS
Corporate Profile
At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. Our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments.
GlycoMimetics is a clinical-stage biotechnology company. We use novel and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. Since the company’s inception in 2003, we have developed a robust, diversified product pipeline.
Volume
5:12 pm EST on Jan 25,2021
Copyright Nasdaq. Minimum 15 minutes delayed.
News
January 7, 2021
December 7, 2020
December 5, 2020
Events
Nov 19, 2020 from 6:45 PM to 7:15 PM GMT
Nov 17, 2020 from 8:00 AM to 8:30 AM EST
Nov 6, 2020 8:30 AM EST